Who owns Rigel Pharmaceuticals?

Key details on Rigel Pharmaceuticals (Ticker: RIGL)

Who owns Rigel Pharmaceuticals?

Is RIGL a good stock to own? Find out who bought Rigel Pharmaceuticals, who sold Rigel Pharmaceuticals (RIGL) stock, and who holds a large position in Rigel Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
FMR 13.13M $50.94M March 31, 2014
Wellington Management Company 6.16M $22.35M June 30, 2014
Broadfin Capital 5.60M $20.32M June 30, 2014
Palo Alto Investors 5.17M $20.06M March 31, 2014
OppenheimerFunds 5.00M $18.15M June 30, 2014
T. Rowe Price Associates 4.61M $16.51M Sept. 30, 2013
Vanguard 4.12M $14.95M June 30, 2014
BlackRock Institutional Trust Company, N.A. 3.31M $12.03M June 30, 2014
BlackRock Fund Advisors 3.26M $11.82M June 30, 2014
NEA Management Company 3.24M $11.77M June 30, 2014
BVF 2.58M $10.00M March 31, 2014
Deerfield Management Company 2.40M $8.70M June 30, 2014
Visium Asset Management 2.01M $5.73M Dec. 31, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 1.90M $6.90M June 30, 2014
HealthCor Management 1.80M $14.49M March 31, 2012
Millennium Management 1.78M $6.46M June 30, 2014
D. E. Shaw & Co 1.65M $6.01M June 30, 2014
MORGAN STANLEY 1.52M $5.86M March 31, 2014
STATE STREET CORPORATION 1.50M $5.82M March 31, 2014
HealthCor Management 1.50M $13.76M June 30, 2011